An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility …

C Mukuria, D Rowen, S Harnan, A Rawdin… - … health economics and …, 2019 - Springer
Background Mapping is an increasingly common method used to predict instrument-specific
preference-based health-state utility values (HSUVs) from data obtained from another health …

Treatment of newly diagnosed glioblastoma in the elderly: a network meta‐analysis

E Rogozińska, A Kernohan, S Jefferies… - Cochrane Database …, 2020 - cochranelibrary.com
Background A glioblastoma is a fatal type of brain tumour for which the standard of care is
maximum surgical resection followed by chemoradiotherapy, when possible. Age is an …

Guided imagery and progressive muscle relaxation as a cluster of symptoms management intervention in patients receiving chemotherapy: a randomized control trial

A Charalambous, M Giannakopoulou, E Bozas… - PloS one, 2016 - journals.plos.org
Objective Patients receiving chemotherapy often experience many different symptoms that
can be difficult to alleviate and ultimately negatively influence their quality of life. Such …

Social support buffers the effect of self-esteem on quality of life of early-stage cervical cancer survivors in Taiwan

CC Li, ML Chen, TC Chang, HH Chou… - European Journal of …, 2015 - Elsevier
Purpose The purpose of this study was to examine the effects of self-esteem and social
support on quality of life (QoL) in stage I and II cervical cancer survivors. Method The sample …

Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

LA Gray, M Hernandez Alava, AJ Wailoo - BMC cancer, 2021 - Springer
Background The types of outcomes measured collected in clinical studies and those
required for cost-effectiveness analysis often differ. Decision makers routinely use quality …

Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in colorectal cancer patients

H Ameri, M Yousefi, M Yaseri, A Nahvijou… - Journal of …, 2020 - Springer
Purpose Patient-level utility data are needed for cost-utility analysis; in oncology, however,
the data are commonly gathered using disease-specific questionnaires that are often not …

Cost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States

M Huang, Y Lou, J Pellissier, T Burke… - Journal of medical …, 2017 - Taylor & Francis
Objectives: This analysis aimed to evaluate the cost-effectiveness of pembrolizumab
compared with docetaxel in patients with previously treated advanced non-squamous cell …

Health state utilities in patients with advanced non-small-cell lung cancer in China

Y Shen, B Wu, X Wang, J Zhu - Journal of Comparative …, 2018 - becarispublishing.com
Aim: Non-small-cell lung cancer (NSCLC) is a leading global health threat that impairs
patient health outcomes. Health state utilities are fundamental values in economic …

Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients

H Ameri, M Yousefi, M Yaseri, A Nahvijou… - Expert review of …, 2019 - Taylor & Francis
Introduction: Economic evaluation of healthcare interventions usually needs accurate data
on utility and health-related quality-of-life scores. The aim of this study is to map QLQ-C30 …

Mapping the Haem-A-QoL to the EQ-5D-5L in patients with hemophilia

RH Xu, D Dong, N Luo, ELY Wong, R Yang, J Liu… - Quality of Life …, 2022 - Springer
Objective This study's objective was to develop an algorithm that mapping the Haem-A-QoL
scores to EQ-5D-5L utility scores in patients with hemophilia in China. Methods A national …